Jacqueline D. Reeves

7.4k citations

62 papers · 5.2k indexed · 1 hit paper · h-index 31

Virology top 0.1%
Infectious Diseases top 0.2%
Immunology top 1%
Epidemiology top 2%
Molecular Biology top 10%

Co-authors: Graham Simmons Robert W. Doms Paul Bates Andrew J. Rennekamp Scott L. Diamond Dhaval N. Gosalia Andrew J. Piefer Paul R. Clapham
Topics: HIV Research and Treatment (48 papers)HIV/AIDS drug development and treatment (32 papers)Immune Cell Function and Interaction (23 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Science Proceedings of the National Academy of Sciences Journal of Clinical Investigation
Partner nations: United States United Kingdom Germany

In The Last Decade

Jacqueline D. Reeves

62 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

2005 804 citations Graham Simmons, Jacqueline D. Reeves et al. profile →

Peers

Countries citing papers authored by Jacqueline D. Reeves

Since Specialization

Citations

This map shows the geographic impact of Jacqueline D. Reeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline D. Reeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline D. Reeves more than expected).

Fields of papers citing papers by Jacqueline D. Reeves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline D. Reeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline D. Reeves. The network helps show where Jacqueline D. Reeves may publish in the future.

Co-authorship network of co-authors of Jacqueline D. Reeves

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline D. Reeves. A scholar is included among the top collaborators of Jacqueline D. Reeves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline D. Reeves. Jacqueline D. Reeves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti–HIV-1 Antibodies 2024 ·The Journal of Infectious Diseases ·Marie H. Pahus,Yu Zheng,(unknown),Jesper Damsgaard Gunst,Pablo Tebas,Babafemi Taiwo,Ole S. Søgaard,Michael J. Peluso,Yolanda Lie,Jacqueline D. Reeves,Christos J. Petropoulos,Marina Caskey,Katharine J. Bar	2
2	High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia 2016 ·AIDS Research and Human Retroviruses ·Rebecca Nedellec,Joshua T. Herbeck,Peter W. Hunt,Steven G. Deeks,James I. Mullins,Elizabeth D. Anton,Jacqueline D. Reeves,Donald E. Mosier	2
3	Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis 2013 ·Virology ·Richard J. O. Barnard,Carolyn McHale,(unknown),(unknown),Donald J. Graham,(unknown),Julie Strizki,Peggy Hwang,(unknown),Jacqueline D. Reeves,David C. Nickle,Mark J. DiNubile,Daria J. Hazuda,Niloufar Mobashery	18
4	Drug Resistance and Coreceptor Usage in HIV Type 1 Subtype C-Infected Children Initiating or Failing Highly Active Antiretroviral Therapy in South Africa 2011 ·AIDS Research and Human Retroviruses ·Taryn N. Green,Moherndran Archary,Michelle Gordon,(unknown),Yolanda Lie,Elizabeth D. Anton,Jacqueline D. Reeves,Anneke Grobler,Raziya Bobat,Hoosen Coovadia,Thumbi Ndung’u	16
5	Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),Henry Sunpath,Taryn N. Green,(unknown),(unknown),Yolanda Lie,Elizabeth D. Anton,Richard A. Murphy,Jacqueline D. Reeves,Daniel R. Kuritzkes,Thumbi Ndung’u	18
6	Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells 2011 ·Journal of Clinical Investigation ·Jeffrey M. Milush,(unknown),Vasudha Sundaravaradan,Shari N. Gordon,Jessica C. Engram,Christopher A. Cano,Jacqueline D. Reeves,Elizabeth D. Anton,Eduardo O’Neill,Eboneé N. Butler,Kathy Hancock,Kelly Stefano Cole,Jason M. Brenchley,James G. Else,Guido Silvestri,Donald L. Sodora	54
7	Response to Vicriviroc in Treatment‐Experienced Subjects, as Determined by an Enhanced‐Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211 2009 ·The Journal of Infectious Diseases ·Zhaohui Su,Roy M. Gulick,Amy Krambrink,Eoin Coakley,Michael D. Hughes,Dong Han,Charles Flexner,Timothy Wilkin,Paul R. Skolnik,Wayne Greaves,Daniel R. Kuritzkes,Jacqueline D. Reeves	42
8	Validation of an Enhanced Sensitivity Trofile™ HIV-1 Co-receptor Tropism Assay 2008 ·46th Annual Meeting ·Jacqueline D. Reeves	4
9	Virally Induced CD4+ T Cell Depletion Is Not Sufficient to Induce AIDS in a Natural Host 2007 ·The Journal of Immunology ·Jeffrey M. Milush,Jacqueline D. Reeves,Shari N. Gordon,D. J. Zhou,Alagar R Muthukumar,(unknown),Elizabeth Chacko,Luis D. Giavedoni,Chris Ibegbu,Kelly Stefano Cole,(unknown),Mirko Paiardini,Ashley P. Barry,Silvija I. Staprans,Guido Silvestri,Donald L. Sodora	90
10	A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo 2006 ·Virology ·Stefan Pöhlmann,Jan Münch,(unknown),Jacqueline D. Reeves,Claas Otto,George J. Leslie,Heike Hofmann,Bridget A. Puffer,Frédéric Baribaud,Andrea Marzi,Thomas Gramberg,Zhiwei Chen,Nicole Stolte,Peter ten Haaft,Jonathan L. Heeney,Christiane Stahl‐Hennig,Kerstin Mätz‐Rensing,Thomas Schneider,Robert W. Doms,Frank Kirchhoff	3
11	Emerging Drug Targets for Antiretroviral Therapy 2005 ·Drugs ·Jacqueline D. Reeves,Andrew J. Piefer	94
12	Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques 2003 ·Virology ·Dalma Vödrös,Rigmor Thorstensson,Robert W. Doms,Éva Mária Fenyõ,Jacqueline D. Reeves	17
13	Human Leydig cells are productively infected by some HIV-2 and SIV strains but not by HIV-1 2003 ·AIDS ·(unknown),(unknown),Jacqueline D. Reeves,(unknown),Elaine Thomas,Áine McKnight,Bernard Jégou,Nathalie Dejucq‐Rainsford	17
14	Comparison of CD4-independent infection by HIV-1, HIV-2 and SIV strains, and relevance of receptors other than CCR5 and CXCR4 for infection of primary cell types 2000 ·Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) ·Jacqueline D. Reeves,Graham Simmons,Nathalie Dejucq‐Rainsford,Sam Hibbitts,Áine McKnight,(unknown),José Moniz‐Pereira,Paul R. Clapham	1
15	Inhibition of CXCR4-Dependent HIV-1 Infection by Extracellular HIV-1 Tat 2000 ·Biochemical and Biophysical Research Communications ·Silvia Ghezzi,Douglas M. Noonan,Maria Grazia Aluigi,Giuliana Vallanti,Manuela Cota,Roberto Benelli,Monica Morini,Jacqueline D. Reeves,Elisa Vicenzi,Guido Poli,Adriana Albini	65
16	Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands 2000 ·Immunological Reviews ·Graham Simmons,Jacqueline D. Reeves,Sam Hibbitts,Johnny T. Stine,Patrick W. Gray,Amanda E. I. Proudfoot,Paul R. Clapham	103
17	HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands 1999 ·Molecular Membrane Biology ·Paul R. Clapham,Jacqueline D. Reeves,Graham Simmons,(unknown),Sam Hibbitts,Áine McKnight	47
18	The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2. 1998 ·Journal of General Virology ·Jacqueline D. Reeves,Anne Brelot,L Picard,Marc Alizon,Paul R. Clapham,(unknown)	25
19	CD4-Independent Infection by HIV-2 (ROD/B): Use of the 7-Transmembrane Receptors CXCR-4, CCR-3, and V28 for Entry 1997 ·Virology ·Jacqueline D. Reeves,Áine McKnight,(unknown),Graham Simmons,Patrick W. Gray,Christopher Power,Timothy N. C. Wells,Robin A. Weiss,Simon J. Talbot	123
20	Effect of Mutations in the V3 Loop of HIV-1 gp120 on Infectivity and Susceptibility to Proteolytic Cleavage 1993 ·AIDS Research and Human Retroviruses ·Thomas F. Schulz,Jacqueline D. Reeves,(unknown),Chetankumar S. Tailor,Paul E. Stephens,Gary Clements,(unknown),(unknown),John P. Moore,Robin A. Weiss	35

About Jacqueline D. Reeves

Jacqueline D. Reeves is a scholar working on Virology, Infectious Diseases and Immunology, having authored 62 papers that have together received 5.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (48 papers), HIV/AIDS drug development and treatment (32 papers) and Immune Cell Function and Interaction (23 papers). The work is most often cited by research in Virology (2.9k citations), Infectious Diseases (2.9k citations) and Immunology (1.8k citations). Jacqueline D. Reeves has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Graham Simmons, Robert W. Doms, Paul Bates, Andrew J. Rennekamp, Scott L. Diamond, Dhaval N. Gosalia, Andrew J. Piefer, Paul R. Clapham, Patrick W. Gray and Sean M. Amberg. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact